Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.

Source:http://linkedlifedata.com/resource/pubmed/id/10049056

Download in:

View as

General Info

PMID
10049056